Retinalamin® is is a drug with the proven cellular and molecular effectiveness.
Retinalamin® is a retinoprotector that produces a direct effect on the retina. It launches mechanisms of adaptation to pathological processes and regeneration of retinal neurons improving visual functions in case of glaucoma, diabetic retinopathy and other eye disorders.
The mechanism of action is determined by the metabolic activity of Retinalamin®:
According to the description, Retinalamin® is indicated for:
Dosage and Administration
It is recommended to use the medicine only after a doctor's examination and upon prescription. Administration of Retinalamin® is carried out either intramuscularly or through the skin of the upper eyelid. The depth of an injection is about 1 cm.
The drug should be diluted with 1-2 ml of sodium chloride liquid (0.9%). To prevent foaming, the needle should be pointed closer to the wall of the vial.
The dose and scheme of use depend on the disease and the condition of the patient. Please refer to the official description for the detailed information on the drug administration.
Caution should be taken when driving vehicles and operating machinery during the treatment. Parabulbar injections must be carried out by a qualified medical worker. Always follow the description and your doctor's recommendations.